HEMOSTASIS DIAGNOSTICS MARKET ANALYSIS
Key Development
In February 2019, Horiba Medical, launched their new parameter, Yumizen D-Dimer, for its Yumizen G Hemostasis range of instruments to diagnose deep vein thrombosis and pulmonary embolism.
In 2017, Werfen and it's subsidiary Instrumentation Laboratory Company acquired Accriva Diagnostics, to expand leadership in point of care testing.
In 2016, Siemens Healthineers launched Sysmex CS-2500 a new mid-volume coagulation analyzer. Which enable labs to provide quality test results and achieve cost-effective method consolidation.
In 2015, Roche AG launched the new lab-coagulation solution, the cobas t 411 analyzer is lab coagulation system suitable for low volume routine testing (up to 120 samples per day), with this launch Roche AG expanded their diagnostic portfolio.
In 2014, Sysmex Corporation, launched LIASAUTO P-FDP hemostasis reagent for automated coagulation analyzers to determine the status of blood hyperfibrinolysis and hypercoagulable
Need a Custom Report?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now
Credibility and Certifications
9001:2015
27001:2022
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients
U.S.: 
U.K. : 
India : 
